DermTech Inc (NAS:DMTK)
$ 0.5701 -0.0679 (-10.64%) Market Cap: 19.93 Mil Enterprise Value: 20.84 Mil PE Ratio: 0 PB Ratio: 0.39 GF Score: 44/100

Q4 2023 DermTech Inc Earnings Call Transcript

Feb 29, 2024 / 10:00PM GMT
Release Date Price: $1.28 (-3.76%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to DermTech's fourth-quarter 2023 financial results call. (Operator Instructions) Please be advised that today's conference is being recorded. I would like now to turn the conference over to Steve Kunszabo. Please go ahead.

Steve Kunszabo
DermTech Inc - Senior Director, Investor Relations

Thank you, operator. Welcome to DermTech's fourth-quarter 2023 earnings call. With me on today's call are Bret Christensen, our President and Chief Executive Officer, and Kevin Sun, our Chief Financial Officer.

Our call today will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact are considered forward-looking statements.

Forward-looking statements made during this call, including statements regarding projections of future performance or financial outlook of DermTech, the performance, patient, benefits, cost effectiveness, commercialization, and adoption of our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot